Back
Voya Emerging Markets High Dividend Equity Fund Vs. Neurogene Industry Stock Comparison
Sell
36
IHD
Voya Emerging Markets High Dividend Equity Fund
Last Price:
5.14
Seasonality Move:
1.46%
Sell
5
NGNE
Neurogene
Last Price:
40.25
Seasonality Move:
50.43%
Sell
36
Voya Emerging Markets High Dividend Equity Fund (IHD)
is a Sell
Is Voya Emerging Markets High Dividend Equity Fund a Buy, Sell or Hold?
- The current Voya Emerging Markets High Dividend Equity Fund [IHD] share price is $5.17. The Score for IHD is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- IHD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IHD Stock Price Chart
What is Voya Emerging Markets High Dividend Equity Fund's stock price today?
-
The Voya Emerging Markets High Dividend Equity Fund share price today is $5.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHD is experiencing slight selling pressure.
IHD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 30.51 | Sell |
Chaikin Money Flow: | -23852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.33 - 5.57) | Sell |
Bollinger Bands (100): | (5.28 - 5.54) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
IHD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.31 | Sell |
20-day SMA: | 5.42 | Sell |
50-day SMA: | 5.45 | Sell |
200-day SMA: | 5.32 | Sell |
8-day EMA: | 5.29 | Sell |
20-day EMA: | 5.39 | Sell |
50-day EMA: | 5.43 | Sell |
200-day EMA: | 5.33 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
Voya Emerging Markets High Dividend Equity Fund Earnings Growth & IHD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Voya Emerging Markets High Dividend Equity Fund Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |